Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002403664 | SCV002704169 | likely pathogenic | Diamond-Blackfan anemia | 2015-11-17 | criteria provided, single submitter | clinical testing | The c.165-16_166del18 variant spans the last sixteen nucleotides of intron 2 through the first 2 nucleotides of coding exon 3 in the RPL35A gene. This results in a deletion of 18 nucleotides, including the canonical splice acceptor site. Alterations that disrupt the canonical splice acceptor site are typically deleterious in nature (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). As such, the c.165-16_166del18 variant is classified as likely pathogenic. |